RPG LifeScience.

Market Cap: Small Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE105J01010
NSEID: RPGLIFE
BSEID: 532983

INR

2,085.35

106.35 (5.37%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 7.9 k

Click here to access the older version

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Rs cr

Standalone Quarterly Results

Dec'24

Sep'24

Jun'24

Mar'24

Dec'23

Sep'23

Jun'23

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Dec 2024 is 0.29% vs 4.10% in Sep 2024

Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is 731.67% vs -84.30% in Sep 2024

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2024 is 7.03% vs 17.56% in Sep 2024

Interest

QoQ Growth in quarter ended Dec 2024 is -29.41% vs 13.33% in Sep 2024

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2024 has improved from Sep 2024

Compare Quarterly Results Of RPG LifeScience. With

Select Peers

Figures in Rs cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

172.71

2,396.57

-2,223.86

-92.79%

Other Operating Income

0.00

Total Operating income

172.71

2,396.57

-2,223.86

-92.79%

Raw Material Cost

30.19

179.72

-149.53

-83.20%

Purchase of Finished goods

22.70

445.60

-422.90

-94.91%

(Increase) / Decrease In Stocks

3.22

34.08

-30.86

-90.55%

Employee Cost

28.71

521.79

-493.08

-94.50%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

38.73

474.45

-435.72

-91.84%

Total Expenditure (Excl Depreciation)

123.55

1,655.64

-1,532.09

-92.54%

Operating Profit (PBDIT) excl Other Income

49.16

740.93

-691.77

-93.37%

Other Income

3.31

69.82

-66.51

-95.26%

Operating Profit (PBDIT)

52.47

810.75

-758.28

-93.53%

Interest

0.12

199.47

-199.35

-99.94%

Exceptional Items

0.00

Gross Profit (PBDT)

52.35

611.28

-558.93

-91.44%

Depreciation

5.46

87.03

-81.57

-93.73%

Profit Before Tax

46.89

524.25

-477.36

-91.06%

Tax

11.96

107.87

-95.91

-88.91%

Provisions and contingencies

0.00

Profit After Tax

34.93

416.38

-381.45

-91.61%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

34.93

416.38

-381.45

-91.61%

Equity Capital

13.23

40.06

-26.83

-66.97%

Face Value

8.00

1.00

0.00

Reserves

0.00

Earnings per share (EPS)

21.12

10.39

10.73

103.27%

Diluted Earnings per share

21.12

10.33

10.79

104.45%

Operating Profit Margin (Excl OI)

28.46%

30.92%

0.00

-2.46%

Gross Profit Margin

30.31%

25.51%

0.00

4.80%

PAT Margin

20.22%

17.37%

0.00

2.85%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 172.71 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is 0.29% vs 4.10% in Sep 2024

YoY Growth in quarter ended Dec 2024 is 12.37% vs 17.69% in Dec 2023

Quarterly - Standalone Net Profit

Standalone Net Profit 34.93 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is 731.67% vs -84.30% in Sep 2024

YoY Growth in quarter ended Dec 2024 is 32.01% vs 38.46% in Dec 2023

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 49.16 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is 7.03% vs 17.56% in Sep 2024

YoY Growth in quarter ended Dec 2024 is 29.71% vs 29.75% in Dec 2023

Quarterly - Interest

Interest 0.12 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is -29.41% vs 13.33% in Sep 2024

YoY Growth in quarter ended Dec 2024 is -14.29% vs 100.00% in Dec 2023

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 28.46%

in Dec 2024

Figures in Rs %

QoQ Growth in quarter ended Dec 2024 has improved from Sep 2024

YoY Growth in quarter ended Dec 2024 has improved from Dec 2023